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Phosphate bioactive glasses are the potential substitutes of typical silicate bioactive glasses 
for repair and regeneration of the defected bone due to their resemblance to the natural bone. In 
earlier studies, thermal, bioactive and structural properties of different phosphate bioactive 
glasses were investigated by introducing various elements. Furthermore, in some studies these 
glasses were utilized in scaffolds fabrication using methods like powder technique and foaming 
technique. But these techniques produced scaffolds with reduced mechanical properties due to 
large pores size.  
In this thesis, new phosphate bioactive glasses with compositions; 45P2O5, 2.5B2O3, 2.5SiO2, 
10Na2O, 20CaO, (20-x)SrO, xMgO in mol% (x = 0, 5 ,10, 15 and 20) were prepared with two 
particle sizes i.e. <38µm and 125-250µm. The aim was to develop phosphate bioactive glasses 
that can be sintered without losing their bioactivity. Thermal analysis was performed for these 
glasses in which glass transition and crystallization temperatures were increased with increasing 
amount of MgO. By further increasing the MgO content from 15 and 20 mol%, crystallization 
peaks disappeared. Bioactivity studies were performed in Simulated Body Fluid (SBF) at 37°C. 
The ion release profile was highly function of the particles size, as can be expected from glasses. 
A rapid ion release, within 1 day was seen for the smaller particle size. Larger particle size, 125-
250µm, released ions continuously for 2 weeks. FTIR of the glass structure revealed two new 
bands after 2 weeks time point, especially in the sample substituted with 20 mol% of MgO for 
SrO, that indicated CaP layer formation.  
Based on thermal and bioactive properties, suitable glass compositions were chosen i.e. x = 
10 and 15. These compositions were subjected to scaffold fabrication using robocasting tech-
nique in which printing head movement was controlled by programmed printing script. Ink, pre-
pared from glass powders and Pluronic F-127 binder, was extruded to get three-dimensional scaf-
folds and then further sintered to obtained mechanically stable, amorphous, scaffolds. In-vitro 
dissolution revealed the formation of CaP layer faster and prominent in x = 15 glass scaffold. 
Furthermore, mechanical strength of both compositional scaffolds remained in the range of can-
cellous bone compressive strength even after two weeks of immersion in SBF.  
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1. INTRODUCTION 
Any damage to the tissue caused by disease, trauma, aging or tumor removal requires 
repair and regeneration (Sharif, et al., 2016). When considering bone regeneration, au-
tograft (bone harvested from the patients own body), allograft (graft taken from someone 
else body) and xenograft (graft taken from another species) are used in current treat-
ments. Autograft has been a gold standard for bone replacing for many years. The bone 
is mainly harvested from the iliac crest. Despite being the gold standard, limitations such 
as limited availability, donor site morbidity and chance of infections are drawbacks that 
must be pointed out. Allograft transplantation may cause pathogen transfers, immune 
rejections and risk of infections in recipients’ body. Xenograft is cheap and readily avail-
able but has limitations like ethical issue and chronic rejections (Salgado, et al., 2004; 
Al-Qaysi, 2018). To overcome the limitations of these grafts, biomaterials are being in-
vestigated such as polymers, metals, ceramics and composites. Among these materials, 
ceramics have gained importance due to their bioactive property i.e., they elicit a biolog-
ical response leading to bond formation between tissue and material. (Ratner, et al., 
1996). Examples of ceramics are calcium phosphate ceramics (CPCs) that are tunable 
and have been utilized for bone repair and augmentation. Their surface properties allow 
the osteoblast adhesion and new bone stimulation. Most common CPCs are hydroxyap-
atite and tricalcium phosphate (Dorozhkin & Epple, 2002). Drawbacks of CPCs include 
poor mechanical properties which limits their use in non-load bearing applications, brit-
tleness of the CPCs block which resists in filling bone defect perfectly (Yuan & Groot, 
2005). These limitations gave rise to the research on bioactive glasses. 
In 1969, the first bioactive glass named Bioglass® 45S5 (a silicate glass) developed by 
Professor Larry Hench, exhibited high bioactivity and had the ability to bond to soft and 
hard tissues. His discovery led to the extensive research in the field of bioactive glasses 
(Jones, 2013; Moya, et al., 1999). Bioglass® had two main features i.e., to inhibit foreign 
body reaction, and to form hydroxyapatite (HA) layer, that resembles the main mineral 
phase of the bone, upon immersion in aqueous solution, thus allowing bone healing 
(Hench, et al., 1971). However, thermal processing methods are not suitable for such 
silicate glasses due to induction of extensive crystallization during the process which is 
undesirable for bioactivity and also resist the proper sintering.  (Filho, et al., 1996; 
Massera, et al., 2012). Furthermore, the dissolution of silicate glasses has been well 
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studied and is nowadays well understood (Sepulveda, et al., 2002). The incongruent 
dissolution mechanism of silicate bioactive glasses led to the remnants of silicate bioac-
tive glass after 14 years of operation (Lindfors, et al., 2010). These short comings of 
silicate glasses didn’t make a breakthrough in the clinic which led to the research on the 
different substitutes such as borate and phosphate glasses. 
Phosphate bioactive glasses due to their resemblance to the natural bone, are highly 
attractive as a biomaterial. However, simple phosphate glasses degrade fast and, thus, 
have a low chemical durability. These glasses can be used as a bioresorbable materials 
in applications such as: suture thread and bone fracture fixation (Ahmed, et al., 2004a). 
Phosphate glasses are made bioactive by tailoring their composition, this way, the rate 
of degradation can be controlled and become suitable for use in bone repair and recon-
struction (Bunker, et al., 1984; Clement, et al., 1999). Furthermore, phosphate bioactive 
glasses have good thermal properties and, thus, provide large processing window, as 
evidenced in previous studies on bioactive phosphate fibers (Ahmed, et al., 2004b; 
Massera, et al., 2015). Phosphate bioactive glass family have also been researched, 
lately, by doping with various elements i.e. Ag, Cu and Fe to assess their effect on prop-
erties such as thermal processability, in-vitro dissolution properties and structural prop-
erties (Mishra, et al., 2016; Mishra, et al., 2017; Lopez-Iscoa, et al., 2019).  
Scaffolds, which are porous 3D construct, act as a temporary template in the body. Scaf-
fold degrades after natural healing of the tissues. Selection of the scaffold materials are 
based on future applications (structural support or drug delivery) (Sultana, 2013; Jones, 
2013; Fu, et al., 2011; Khan, et al., 2008). Mostly, bioactive glasses are considered as 
attractive materials for scaffold development due to ease in controlling their chemical 
composition and, thus, degradation rate (Fu, et al., 2011). Scaffolds of phosphate based 
bioactive glasses have been fabricated using techniques such as powder technology 
and foaming technique (Ruiz-Aguilar, et al., 2019). However, production of scaffolds with 
large pores through these techniques results in poor mechanical strength of the scaffolds 
(Erasmus, et al., 2018).  
In this thesis project, the attempt is to produce new phosphate bioactive glasses with 
compositions that can be sintered and also show bioactivity. Five different compositions 
are developed in which MgO replaces SrO by increment of 5 mol% with the aim to study 
the effect of MgO addition on the thermal, structural and bioactive properties of phos-
phate bioactive glasses. MgO is known to increase the crystallization temperature when 
added in the glass composition (Islam, et al., 2017). Successful characterization of these 
glasses allowed to choose two best compositions that can be used to fabricate scaffolds 
using robocasting technique. Characterization of both glass compositions and scaffolds 
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include: differential thermal analysis (DTA) and X-Ray diffraction (XRD) to reveal thermal 
properties, in-vitro dissolution test to examine the bioactivity of the glasses, fourier trans-
form infrared spectroscopy (FTIR) to evaluate structural change of the glass surface and, 
finally, compression test of fabricated scaffolds to observe mechanical strength. Suc-
cessful results from these analyses pave the way for these phosphate glasses to appli-
cation in bone tissue engineering applications. 
This thesis comprises of theoretical background (chapter 2) in which key concepts re-
lated to this thesis are given, materials and methods (chapter 3) where experimental 
work done in this thesis is explained, results and discussion (chapter 4) in which obtained 
results are mentioned and discussed. Finally, conclusion and key findings of the thesis 
project are presented in chapter 5. 
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2. THEORATICAL BACKGROUND 
2.1 Bone tissue engineering 
Current clinical treatments for bone defects have some limitations and complications 
such as donor site morbidity, immune rejection, shortage of bone grafts and pathogens 
transfer. Bone tissue engineering is a relatively new field which focuses on alternative 
treatment options that could ideally suppress these issues in a reliable, affordable and 
physiologically acceptable manner (Sultana, 2013; Amini, et al., 2012). 
2.1.1 Bone 
The human skeleton is made up of approximately 206 bones which are distributed in 
axial skeleton that contains skull, sternum, vertebrae, ribs and hyoid and the peripheral 
skeleton that includes limps and pelvis bones. All together their function is to provide 
mechanical strength, maintain structure and shape of the body, protect organs from ex-
ternal damage, help in locomotion of the body and act as a reservoir for the cytokines 
and growth factors. Bones in their life-time constantly model to adapt the biomechanical 
forces and remodel to keep themselves strong by replacing old and weak bones with 
new and mechanically stronger bones. (Kardamakis, et al., 2009, p. 4; Clarke, 2008). 
According to anatomy, a human bone has three components including periosteum, the 
cortex and the medulla. Periosteum separates the bone from soft tissues due to its pres-
ence at the outer surface of the bone and also maintain the shape and size of the bone. 
It has two layers i.e. inner cellular layer and outer fibrous layer. Inner layer contains cells 
such as osteoprogenitor, fibroblasts and osteoblasts along with sympathetic nerves and 
microvessels. Outer layer contains fibroblasts cells, collagen, elastin fibers along with a 
network of blood vessels and nerves. Inner layer reduces its cellularity with age. The 
cortex is a thick part of the bone that is present below the periosteum. It is made up of 
compact bone. Due to its hardness, it is in great proportion in long bones which also 
handles the mechanical forces. Last component, medulla of the bone is comprised of 
cancellous bone which is spongy in shape and its percentage is more in bones of verte-
bral column (Kardamakis, et al., 2009). 
Bone cells, despite contributing for less than 2% to the bone mass formation, play an 
important role in bones functionality. They are of four types: osteoblasts, osteocytes, 
osteogenic cells, and osteoclasts (Figure 1). Osteoblasts are present in the growing part 
of the bone and are responsible for mineralizing and making new bones. Osteoblasts 
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secrete collagen especially type-1 and other proteins which help in bone formation. 
Eventually they get trapped in collagen matrix and turn into osteocytes. Osteocytes are 
the most common types and primary cells of the mature bone. Its function is to regulate 
the mineral concentration in the matrix by secreting enzymes. Osteoblasts and osteo-
cytes lack the ability to divide, therefore, they are osteogenic cells also called osteopro-
genitor cells which differentiate into osteoblasts when the old ones die. They are the only 
bone cells which divide and are present in the periosteum and the endosteum cellular 
layer. Last cell type are osteoclasts, produced by macrophages and monocytes and are 
multinucleated, resorb unnecessary and injured bones to release minerals from the bone 
tissue (Biga, et al., 2019). Improper function of osteoclasts can lead to several bone 
diseases, including Paget disease (formation of disorganized bone tissue), osteoporosis 
(non-compensable bone resorption) and osteopetrosis (bone becomes hard due to less 
resorption of bone by osteoclasts) (Kardamakis, et al., 2009).   
 
Figure 1. Bone cell types and their positions (Biga, et al., 2019) 
 
The change in factors like person’s age, gender, disease, bone deformation rate, 
its location and porosity highly affect the mechanical properties of the bone. It has been 
observed that moisture and mineralization have a great impact on bone rigidity. Table 1 
shows the mechanical strength of a healthy human cancellous and cortical bone 
(Chittibabu, et al., 2016; Fu, et al., 2011). 
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Bones  
Compressive 
strength 
(MPa) 
Flexural 
strength 
(MPa) 
Tensile 
strength 
(MPa) 
Modulus 
(GPa) 
Porosity 
(%) 
Fracture 
toughness 
(MPa·m1/2) 
Cancellous bone  2-12 10-20 1-5 0.1-5 0.1-0.8 50-90 
Cortical bone  100-150 135-193 50-151 10-20 2-12 5-10 
2.1.2 Allopathic medicine 
Bone repair and regeneration is required when the tissue is damaged due to disease, 
aging, traumatic injuries or tumour removal. According to the report, in U.S, each year 
approximately 6.2 million bone fractures occur and about 10% do not recover properly. 
10 million people are affected by osteoporosis and an increase by 4 million is expected 
by 2020, which is expected to lead to 25 billion dollars expenditure on healthcare annu-
ally. After blood, bone is believed to be the most transplanted tissues in the body. Every 
year around 2.2 million bone grafts are surgically implanted globally to aid bone healing 
(Fu, et al., 2011; Jones, 2013). It should be noted that bone repair reinstates the physi-
ological structure of the bone whereas, bone regeneration is the process of forming new 
bone tissue (Al-Qaysi, 2018). 
Bone grafting is one of the treatments used when the bone is fractured or part of it is 
absent. Common approaches for bone grafting are autografts, allografts and xenografts. 
Autograft can be extracted from patient´s own body and are osteoconductive, osteoin-
ductive, and osteogenic. It is the gold standard approach in treating bone defects. How-
ever, it has limitations like extracted graft may not cover the large defect, donor site in-
fection, morbidity, chronic pain after extraction and concerns about availability due to 
limited supply of the tissue (Sharif, et al., 2016; Edward, et al., 1996). Allograft is har-
vested from some other individual that, unlike autografts, can cover wider bone defects 
but the major drawbacks are disease transmission, evoking of immunological responses 
and high cost (Fu, et al., 2011; Sharif, et al., 2016). Deproteinated xenografts are ex-
tracted from bovine or pig to make inorganic bone scaffold. Their use in bone repair is 
limited because of personal, ethical and religious issues (Al-Qaysi, 2018). 
Synthetic bioinert metals and polymers are also used in the treatment of defected tis-
sues. Due to their inert behaviour they may cause severe inflammation as body does not 
accept them and as a result fibrous capsule is formed and surrounds the implant (Kress, 
et al., 2012). The bond between implant and fibrous capsule is typically weak which af-
fects the implant performance that leads to repeated surgeries which consumes patient’s 
Table 1. Mechanical properties of cancellous and cortical bones (Fu, et al., 2011). 
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money and in return keeps the patient in discomfort (Jones, 2013; Nair & Laurencin, 
2007). 
2.1.3 Tissue engineering approach 
Tissue engineering (TE) combines the methods and principles of engineering and life 
sciences to understand the relationship between healthy and diseased living tissue in 
order to develop the biological substitutes that restore the normal function of the body. 
TE has overcome the limitations of conventional treatments by introducing constructs 
and 3 dimensional porous scaffolds. Scaffolds, which mimic the properties and structure 
of the tissue are used in TE. They are typically fabricated according to the desired shape 
and size. Cells are embedded in scaffold with signaling molecules if needed which, later 
on, are cultured in a bioreactor before they are implanted in the patient. Implanted scaf-
fold act as a temporary substrate and provide necessary support to the cells (Sultana, 
2013).  
Bone Tissue Engineering (BTE) is an emerging field that helps in regenerating bone 
tissues and restoring the functions with the help of osteoconductive scaffolds, osteogenic 
progenitor cells and osteoinductive growth factors (Sultana, 2013). BTE understands the 
biology and mechanics of the bone so that it can regenerate the new functional bone 
(Amini, et al., 2012). Scaffold is synthesized using biodegradable material which after 
temporary support degrades to stimulate the body’s own healing mechanism and allow 
the natural healing of the bone (Jones, 2013). 
Biological based approaches of BTE involve using cells and biomolecules to aid the re-
pair and regeneration of the bone incorporated by biomaterials that give structure sup-
port and act as a platform for testing the viability of different biological parameters (Li, et 
al., 2017). As an example, hypertrophic cartilaginous constructs were obtained by grow-
ing rat nasal chondrocytes on a polyglycolic acid (PGA) scaffolds which were implanted 
into the rat cranial defect site. The process called analogous to endochondral ossification 
that resulted in angiogenesis, mineralization, and remodelling of the cartilage into bone 
(Bardsley, et al., 2017). Similarly, engineering-based approaches for BTE are mainly 
dependant on different techniques such as 3D printing and robocasting to produce ce-
ramic bone graft substitutes with enhanced mechanical and structural properties that 
facilitates bone regeneration (Li, et al., 2017).    
8 
2.2 Synthetic biomaterials for TE 
In regenerative medicine (RM), especially TE, biomaterials are the most important com-
ponents of latest techniques that provide guidance and facilitate the behaviour and func-
tion of the cells. Latest techniques include cell therapies, where cells or matrices are 
delivered to the in-vitro constructed tissues by the carriers and in acellular therapies, 
where cells are stimulated by the materials to grow and differentiate from the healthy 
residual tissues in-situ. Materials used in such techniques provide three-dimensional 
support to control cell behaviour and guide the tissue formation and regeneration (Lutolf 
& Hubbell, 2005).  
Tissues and organs have been reconstructed and regenerated using synthetic materials 
for about 100 years. Synthetic biomaterials should be biocompatible, biodegradable, 
have the mechanical, chemical and biological features such as eliciting an appropriate 
host response in order to be used in the body. The first ever implant materials were bio-
inert in nature and were used to support the mechanical function of the tissue. Later 
biomaterials were developed to be degradable and bioactive. In RM, variety of materials 
are used like metals, ceramics and polymers whose properties can be altered for use in 
different applications of TE like augmentation of existing tissues, new tissue growth pro-
motion or replacement of the whole organ. Degradable materials are essential in the 
body where tissues need temporary support after which they heal themselves and allow 
the material to degrade eventually. Whereas, non-degradable implants have their own 
importance when it comes to replacing the damaged tissues function (Samavedi, et al., 
2014).  
Specifically, BTE requires materials that in addition to the properties above, also promote 
progenitor cells differentiation (Osteoinductive), facilitate native bone growth (Osteocon-
ductive) and have the tendency to connect with the surrounding bone (Osteointegration 
property) (Stevens, 2008).  
2.2.1 Ceramics  
Ceramics used as biomaterials are usually called bioceramics. Generally, they are from 
synthetic or natural origin such as animal skeleton (hydroxyapatite or calcium carbonate) 
(Ben-Nissan, 2003). They are used as an alternative to metallic implants for repair and 
regeneration of defected parts of the body mostly in bone grafts and cements, dental 
implants, and orthopaedic load bearing coatings (hip acetabular cup) applications 
(Salinas & Regi, 2013). Biocompatibility, osteoconductivity, hard brittle surface, and cor-
rosion resistance are the excellent properties found in bioceramics (Hasan, et al., 2013). 
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Ions, such as strontium, zinc, magnesium, manganese, and silicon release during re-
sorption of bone grafts can affect positively on bone health and increases biocompatibil-
ity and mechanical properties of the implant. There are three types of bioceramics used 
in TE applications namely: Bioinert, bioactive, and bioresorbable bioceramics (Pina, et 
al., 2017).   
Bioinert bioceramics include Alumina (Al2O3) and Zirconia (ZrO2), which do not partici-
pate in biological activities due to their chemical inertness hence do not form bond with 
host tissues (Huang & S., 2014). They have high strength, hardness, cracking and cor-
rosion resistance which make them suitable for applications in orthopaedics and dentis-
try (Figure 2). Alumina ceramics alone doesn’t have sufficient fracture toughness there-
fore, zirconia is mixed with alumina to make zirconia-toughened alumina which not only 
increase toughness but also improve the wear properties. Zirconia based ceramics are 
well used in BTE due to its great mechanical properties: flexural strength above 1000 
MPa and fracture toughness >8MPam1/2 respectively (Pina, et al., 2017). 
 
 
Figure 2. Dental implants and hip joint prosthesis made of alumina and zirconia 
based ceramics (Pina, et al., 2017).  
 
Bioactive materials are the bioceramics that essentially facilitate the process of repair 
and regeneration of the bones when they are implanted in the body. Bioactive materials 
are famous because when they are introduced in the body, they get chemically bonded 
to the tissues (Kumar, et al., 2018; Bhushan, et al., 2015). Bioactive glasses and glass-
ceramics are the examples of bioactive materials which are brittle and widely used in 
small bone damage filling and periodontal defects (Pina, et al., 2017). Whereas, biode-
gradable materials are completely degraded in the body after their specific time. Their 
chemical structure gets denatured by the body fluid and the chemicals released by them 
do not cause any toxic effects in-vivo. The biggest advantage of these materials is that 
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a patient doesn’t need second surgery for their removal or adjustment. Calcium phos-
phate ceramics and HA are examples of biodegradable and bioactive bioceramics 
(Kumar, et al., 2018).  
2.2.2 Polymers  
Polymers in the form of natural and synthetic biomaterials, have been widely used in the 
TE and RM to fabricate scaffolds and also medical devices. Natural polymers are con-
sidered to be the first biodegradable materials used in clinical applications. They have 
the edge of possessing broad chemical, physical and bioactive properties that improve 
the cell performance in-vivo. Natural polymers that are used in TE are divided into two 
major classifications i.e., proteins and polysaccharides (Tang, et al., 2014; 
Dhandhayuthapani, et al., 2011).  
Proteins are famous for degrading naturally in a controllable manner and are present in 
the natural tissue in a large amount. Because of their degradation properties, they are 
widely used as suturing material, drug delivery vehicles and scaffold materials etc. Pro-
teins may include collagen, gelatin, elastin, silk, albumin, fibrin, keratin and chitosan. 
Whereas, polysaccharides are made up of many monosaccharides chains through gly-
coside bond or linkages. Chitosan, alginic acid, hyaluronic acid, cellulose and chondroitin 
sulfate are the polysaccharides used in different applications of TE. They are widely uti-
lized in research due to their role in immune recognition and cell signalling (Tang, et al., 
2014). 
In general, guidance provided by synthetic biomaterials are useful in restoring the struc-
ture and function of damaged tissues. Similarly, synthetic polymers are preferred to be 
used in TE applications because their properties can be altered according to the require-
ments. They can be manufactured in large amount and in controlled condition and also 
possess long shelf time. Synthetic polymers possess good mechanical and physical 
properties (elastic modulus, tensile strength and degradation rate). Examples of syn-
thetic polymers are PLA, PGA and its copolymer like PLGA which are mostly used in TE 
(Dhandhayuthapani, et al., 2011; Gunatillake, et al., 2006). Drawback is that the synthetic 
biodegradable polymers like PGA and PLLA exhibit inadequate degradation time when 
used as a scaffold. PGA and its copolymer PLLA reduce its tensile strength to 50% and 
resorb fast on the other hand, PLLA takes too much time to degrade when used in Scaf-
fold material (Ikada, 2006). In general, polymers are not stronger than ceramics therefore 
ceramics are preferred over polymers for load-bearing applications (Chen, et al., 2012). 
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2.2.3 Composites  
Composites come into being when more than one material and their properties combine 
to form one material with synergistic properties. When composites are used as a bio-
material, they are termed as biocomposites. Biocomposites, for the clinical use, are the 
combination of polymer-polymer, polymer-ceramic or ceramic-ceramic. Scaffold with 
these combinations have both biological and mechanical properties and is the better 
substitute over autograft or allograft.  (Basha, et al., 2015).  
The reason behind designing biocomposites is to overcome the flaws of individual ma-
terial. Examples of biocomposites with different compositions may include collagen 1 
with TCP, self-reinforced polymers (PLLA, PLGA) with calcium phosphate, and collagen 
2 with HA bioceramics (Yeo & Kim, 2011). Furthermore, porosity can be induced in com-
posites by different techniques like thermally induced phase separation, wet spinning, 
and electrospinning to make them applicable in BTE (Al-Qaysi, 2018). 
Despite of the many advantages of composites in TE, there remain some challenges that 
need to be overcome. Firstly, designing of the composites and their variables are very 
complex as compare to monolithic traditional materials. Satisfactory biocompatibility test 
of composite implants has not been achieved yet because the response of composites 
components interacting with each other are not completely understood. Lastly, fatigue 
behavior of the composite materials after being implanted in the body is difficult to assess 
than traditional materials like metals and polymers because composite materials are in-
homogeneous and anisotropic unlike materials like metals therefore, there can occur 
different types of damage like fibre fracture, matrix cracking, delaminations etc. inde-
pendently or interactively. Hence, standards for their examinations are still in progress 
(Salernitano & Migliaresi, 2003; Degrieck & Paepegem, 2001). 
 
2.3 Bioactive glasses  
Professor Larry Hench invented the very first bioactive glass in 1969 at the University of 
Florida. Its development started with an idea that it would have strong interface with 
tissues like bone. Professor Hench came up with the glass named 45S5 (Bioglass®) 
having composition (46.1SiO2, 24.4Na2O, 26.9CaO and 2.6P2O5) in Mol%. This glass 
implant appeared to be so strongly bonded with the rat femur bone that bone broke dur-
ing implant removal. This invention of Professor Hench launched the bioactive glass re-
search field that further allowed the development of new products by varying composition 
of bioactive glasses that lead to the improvement in processability and bioactivity (Jones, 
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2013; Hench, et al., 1971; Pacheco, et al., 2015). Bioactive glasses exhibit bioactivity 
which refers to the ability of the material to bond to host tissue as a result of biological 
reaction at the interface. After the Hench discovery till now, many of the bioactive glasses 
with different compositions (mentioned in Table 2) have been developed for various mod-
ern and traditional clinical applications. For instance, one of the compositions from the 
table below, bioactive glass (S53P4) is a special glass developed with the composition 
(53SiO2, 20CaO, 23Na2O, 4P2O5) in wt.% which is utilized in maxillofacial reconstruction 
such as clinical frontal sinus obliteration, orbital floor reconstruction etc., (Peltola, et al., 
2006; Aitasalo, et al., 2001). Similarly, silicate and phosphate based bioactive glasses 
when doped with metal oxides (Ga2O3, Ag2O and CuO), become useful material for 
wound healing applications. Therefore, variations in bioactive glasses is needed for dif-
ferent requirements of the clinical applications (Ylänen, 2011). 
 
 
 
Hench’s discovered glass was a silicate glass having network of SiO2 making up the 
three-dimensional glass structure. 45S5 glass shows bioactivity due to its low content of 
SiO2, high glass network modifiers content (Na2O and CaO) and in addition, high 
CaO/P2O5 ratio (Rahaman, et al., 2011). Glass network modifiers create non-bridging 
oxygen (NBO) groups which denature the silica glass network. Connection of the silica 
glass network reduces an increase in the NBO which also results in increased reactivity 
due to decrement of silicon-oxygen bridges. On the other hand, phosphorus establishes 
bonds with oxygen atoms like silicone (Ylänen, 2011, pp. 3, 4, 17). 
Table 2. Table shows the different composition of bioactive glass researched globally 
(Pacheco, et al., 2015). 
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Bioactive glasses have that special features of promoting the bone cells growth and bond 
to surrounding hard and soft tissues through chemical reactions. These glasses are at-
tractive because by changing their chemical compositions, rate of degradation can be 
controlled enabling fabrication of glass scaffolds with variable degradation rates with re-
spect to bone ingrowth and remodelling. Moreover, upon their implantation, ions released 
trigger the osteogenic genes expression and stimulate angiogenesis (Fu, et al., 2011). 
When bioactive glass is immersed in biological solution, the chemical reaction takes 
place at the surface of the glass and, as a result, a HA layer is formed. This HA layer is 
responsible for the glass bonding to the hard tissue (Rahaman, et al., 2011). The reactive 
layer adsorbs proteins from the biological fluid on the surface which let the osteoprogen-
itor cells attach and the process of proliferation and differentiation to the mature osteo-
blasts takes place (Hench & Polak, 2002). At last, glass degrades, and new bone takes 
its place. Matching of bone formation with the material degradation is ideally preferred. 
For better understanding, as an example, whole process of glass-biological fluid interac-
tion including its timeframe is further explained in Figure 3 (Hench, 1998). 
 
 
Figure 3. Reaction steps between bone and implant surface causing the formation 
of new bone. (Hench, 1998). 
  
There are two methods by which bioactive glasses are formed i.e., melting process and 
sol-gel processing. In biomedical applications, usually melt-derived bioactive glasses are 
utilized (Will, et al., 2012). These glasses come into being after two processes. Firstly, 
high purity raw materials, mostly carbonates, are homogeneously mixed and melted in a 
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furnace at temperature between 1000-1500 ⁰C for time varying between 1-24 hours de-
pending on glass batch size and chemistry (Ylänen, 2011, p. 6). Secondly, molten form 
of the glass is casted and further annealed. Also, small fragments or frit of the frozen 
glass can be obtained by pouring the glass-melt into water (Will, et al., 2012, p. 200; 
Jones, 2013).  
The second method for manufacturing glass is the sol-gel processing. In this method, 
glass is obtained by making a gel using chemistry-based processing such as, conden-
sation and gelation reactions of metal alkoxide in solution. Later the gel turns into glass 
when heated and drying (Will, et al., 2012). Sol-gel process can be altered by controlling 
process chemistry and it can be performed at RT. Glass obtained from this process is 
usually nanoporous with the increased reactivity and decreased mechanical properties 
(Rahaman, et al., 2011).  
 
2.4 Phosphate Bioactive glasses 
Phosphate glasses have been researched over one hundred fifty years (Graham, 1833). 
History of the simple phosphate glasses and their different structures have been dis-
cussed in detail by Brow (Brow, 2000). In biomedical field, these glasses have been 
researched to be used in the applications like controlled release vehicles of antibacterial 
ions such as copper, silver, zinc, and gallium and for 3D construction of the muscular 
tissues (Valappil, et al., 2007). Phosphate based glasses can be shaped into fibres by 
spinning, for use in soft tissue engineering applications as guides for muscle or nerve 
repair (Jeans, et al., 2007; Shah, et al., 2005). When Al2O3 and Fe2O3 are mixed with 
phosphate glass fibres, they can be employed as cell guides and as reinforcing materials 
for skeletal muscles regeneration and myotubes formation. Phosphate glass fibres have 
been tested in-vivo as a nerve guide and positive results obtained which termed phos-
phate glasses as smart materials. (Shah, et al., 2005; Ahmed, et al., 2004c; Kaur, et al., 
2013). For BTE, phosphate glasses are regarded as bone tissue regenerative materials 
in the form of bulk or powders when mixed with polymers in composites materials. (Kaur, 
et al., 2013).  
P2O5 as glass forming network and CaO and Na2O as modifiers, both contributes to form 
phosphate bioactive glasses. These glasses and bone have the same chemical resem-
blance as the constituent ions of phosphate bioactive glasses are also present in the 
organic mineral phase of the bone. Degradation rate of these glasses can be controlled 
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by simply modifying the glass composition. Thus, phosphate glasses appear to be a po-
tential candidate for biomedical use as resorbable materials (Rahaman, 2014). An apa-
tite-like layer usually termed as calcium phosphate layer forms on the surface of all phos-
phate bioactive glasses. Its thickness increases with increase in immersion time that 
allows the adhesion, proliferation and differentiation of cells. According to one study, the 
presence of SrO and MgO in the apatite layer restrict the leaching of phosphate in the 
solution which result in increased durability of phosphate glasses (Massera & Hupa, 
2014; Massera, 2016). Phosphate bioactive glasses exhibit wide hot working domain 
which proves their good thermal properties as evidenced by the large amount of phos-
phate bioactive glass fibres studied in previous years (Ahmed, et al., 2004a; Massera, et 
al., 2015).  
Despite of the vast range of glass compositions, weight loss as a function of time and 
the concurrent release of ions from the glass remain linear resulting in constant release 
of ions from the glass during its lifetime. Phosphate bioactive glasses show more con-
trolled rate of dissolution than the silica-based glasses. Silicate bioactive glasses show 
variation in ions release by the passage of time (Salih, et al., 2000; Ahmed, et al., 2004a).  
Structurally, the basic building blocks of phosphates are phosphate tetrahedra which 
combines to form phosphate networks. Phosphate tetrahedra have different number of 
bridging oxygens such as cross-linking network (Q3), polymer-like chain (Q2+Q1) or small 
pyro-(Q1) and orthophosphate groups (Q0). Whereas, Qi terminology is used to classify 
tetrahedra, in which ‘i’ represents the number of bridging oxygens (BO) that link tetrahe-
dra with each other as shown in figure 5. (Brow, 2000). P-O bond length varies between 
BO to non-bridging oxygen (NBO). As phosphate tetrahedra have an average P-O bond 
length of about 1.54-1.57 Å. Whereas, P-O bond length for BO is about 1.61-1.64 Å, but 
for NBO, the P-O bond lengths decrease systematically for Q3, Q2, Q1 and Q0 tetrahedra 
(Ma, 2014). 
 
Figure 4. Example of phosphate tetrahedra in phosphate network (Brow, 2000). 
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Phosphate glasses applications and properties are compositions dependant. Though 
they are commercialized for various applications as they show efficient physical proper-
ties including controllable chemical durability in liquid solution, low melting and pro-
cessing temperatures and high thermal expansion coefficient (Brow & Tallant, 1997; 
Bunker, et al., 1984). As bioactive (Na2O-CaO-P2O5) glasses have good biocompatibility 
accompanied by amazing degradable properties with low toxicity and minimal inflamma-
tory response (Ahmed, et al., 2004b; Gough, et al., 2002; Gough, et al., 2003), when 
copper and silver are added to the phosphate glasses, can be suited for local treatment 
of the infections (Mulligan, et al., 2003a; Mulligan, et al., 2003b).  
 
2.5 Scaffolds 
Scaffolds are defined as porous three-dimensional constructs acting as a substrate in 
the body to temporarily replace and support parts of tissues by facilitating cells prolifer-
ation and differentiation functions that lead to natural healing process of the tissues. 
There are some necessary requirements for the scaffolds to be fulfilled for use in BTE 
such as biocompatibility, osteoconductivity, osteoinductivity, osteogenecity, osteointe-
gration, interconnected porosity and mechanical properties. Because success and ap-
plicability of BTE are achieved by the performance of the scaffolds (Sultana, 2013; 
Jones, 2013; Fu, et al., 2011). 
Adult mammal is incapable of regenerating tissues fast (except small bone defect) that 
have been removed or lost as a result of accident or surgery, this is where scaffolds help 
to accelerate the wound healing process. Scaffolds along with proper cell seeding den-
sity and/or growth factors might heal the critical size bone defects. Being an artificial 
matrix, scaffolds can not only perform as a guide or template for adhesion, growth and 
function of the cell but also synthesize extracellular matrix (ECM) which results in new 
tissue generation. Selection of materials to develop the scaffolds as a matrix totally de-
pends upon the final application, whether they will be used as structural support or drug 
delivery capability or both. Usually polymers, ceramics, and composites are preferred. 
Ideally, scaffolds should be degraded as new tissue regenerates and replace them nat-
urally (Khan, et al., 2008).  Figure 5. presents the key factors involved in scaffolds de-
signing. 
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Figure 5. An illustration of the most important elements to be considered in BTE 
while designing scaffolds (Will, et al., 2012) 
 
It is expected from the scaffold material to be biocompatible for cell attachment, prolifer-
ation and differentiation. In BTE, more focus is on osteoconductivity and bioactivity while 
creating the material to facilitates the scaffold-bone bond formation and bone growth, 
which also prevent the encapsulating fibrous tissue formation (Will, et al., 2012). Regen-
eration of osseous tissue requires from the scaffold material: a lack of immunogenic re-
sponse, osteoconductivity (the interconnected porous structure allows cells attachment, 
proliferation and migration through the pores along with the nutrient-waste exchange and 
penetration of new vessels), osteoinductivity (stimulation of new bone growth on the im-
plant away from the bone–implant interface) osteogenecity (production of minerals by 
the osteoblasts at the site of new bone formation to calcify the bone matrix that is re-
sponsible for making substrate for new bone), and osteointegration (new formed miner-
alized tissue must bond with implant material) (Khan, et al., 2008; Jones, et al., 2007). 
Furthermore, an ideal scaffold for BTE has adequate interconnected porosity where cells 
can migrate, nutrients can be delivered, and cellular waste can be removed. Specifically, 
size of the pores <50µm is considered essential for cell and protein adhesion, cell migra-
tion and osteointegration. Whilst, pores size more than 300µm enables the new bone 
formation, larger bone ingrowth and vascularization (Will, et al., 2012, p. 200). At least, 
50% porosity is required in the scaffold for adequate tissue ingrowth (Rahaman, et al., 
2011). It should be noted that where large pores size of the scaffold favors the biological 
activity, at the same time negatively affects the mechanical properties of the scaffold. 
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Therefore, compromises are there between mechanical and biological performances 
(Tomlins, 2016, p. 39; Jones, 2013). 
Bones in the different sites of the patient’s body possess different physical and mechan-
ical properties, which demands scaffold properties to be altered accordingly for different 
applications. Furthermore, physical loading affects the bone remodelling therefore, 
matching of the strength of both scaffold material and bone is necessary to provide suf-
ficient mechanical stimulus but stress-shielding should be avoided at the same time 
(Sultana, 2013; Fu, et al., 2011).  
2.5.1 Scaffold Fabrication Techniques 
 
Since, success of the bone defect treatment is dependent on the properties of the scaf-
fold, therefore, it is necessary to consider the choice of raw materials and optimization 
of the processing methods. At present, there are no specific fabrication techniques or 
material that are perfect for all clinical applications (Hutmacher, 2000). Adjustment of the 
processing parameters for the choice of material is needed to fulfil the scaffolds structure 
criteria (Tomlins, 2016, pp. 30-34; Hollinger, et al., 2004, pp. 159, 160).Some of the fab-
rication techniques which are extensively used to produce porous bone scaffolds are 
chemical/gas foaming, particle/salt leaching, freeze drying, solvent casting, thermally in-
duced phase separation, and foam-gel method. These methods are not efficient when it 
comes to controlling scaffold shape, pore size and their interconnectivity. Custom de-
signing of the scaffolds for specific application cannot be obtained through these ap-
proaches (Bose, et al., 2013). For example, one technique is porogen burn-off method 
which is one of the oldest techniques used to produce bioactive glass scaffolds. This 
method employs bioactive glass powder and organic particles, both are mixed and 
heated which results in decomposition of the organic matter that yield the scaffold with 
porous structure. Porogen burn-off method is simple and cost-effective in terms of scaf-
fold production but in this process, controlling size distribution of the pores is difficult and 
also if sacrificial material is not fully evaporated, can negatively affect the sintering pro-
cess of the scaffolds (Brovarone, et al., 2006; Jones, 2013; Chevalier, et al., 2008).  
Currently, most advanced techniques used to produce scaffolds are additive manufac-
turing (AM) approaches, which were introduced in 1986 by Chuck Hull. These ap-
proaches include solid free form fabrication (SFF), stereolithography (SL), rapid proto-
typing (RP) or robocasting, selective laser sintering (SLS), and fused deposition model-
ling. In some research papers these techniques are separately described whereas, in 
others, they are counted as synonyms for single technique. No doubt that they have 
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gained great scientific interest because scaffolds designed and fabricated via these tech-
niques show controlled shape, pore size, and interconnectivity and also made it possible 
to easily tailor the scaffold properties by simply changing parameters. In these ap-
proaches scaffolds are formed in a layer-by-layer fashion from a computer aided design 
(CAD) file or text file, without the use of traditional tools such as dies or moulds. (Bose, 
et al., 2013; Fu, et al., 2011; Baino, et al., 2019). For instance, Tesavibul et al. discovered 
a special AM method named as lithography-based additive manufacturing technique dur-
ing his research in producing Bioglass® based scaffolds. This technique proved to be 
better than SLS and powder-based 3D-printing. In this technique, glass or ceramic parts 
are produced by processing photopolymer which basically contains a great amount of 
glass or ceramic particles. Figure 6. Shows scaffold fabricated using lithography-based 
AM technique (Tesavibul, et al., 2012).  
 
Figure 6. A picture presents Bioglass® based scaffold produced using lithography-
based AM technique. Cropped from (Tesavibul, et al., 2012). 
 
However, AM techniques have few challenges such as, processing time and require 
complex and costly equipment. Post-processing is necessary after scaffolds fabrication 
such as sintering, in which, there is a risk of non-uniform shrinkage of the scaffolds which 
may cause cracking in the scaffolds parts. Also, selection of the binders in the material 
and their removal during the sintering are great challenges to be considered. Despite of 
these limitations, AM techniques have great potential in the future requiring extensive 
optimization before the high-quality parts can be made (Bose, et al., 2013; Ylänen, 2011, 
p. 168; Woodruff & Hutmacher, 2010).     
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2.5.2 Robocasting of Bioactive glass scaffold 
 
Currently, information found in the literature about the production of bioactive glass scaf-
folds is limited using additive manufacturing approaches. Robocasting technique, how-
ever, seems to be powerful and commonly adopted technique for fabrication of glass and 
glass-ceramic scaffolds. In this direct-writing method, robot-controlled nozzle extrudes 
ink continuously in the form of filament in a 3D fashion (layer-by-layer) on the surface of 
building platform to construct three-dimensional structure. Printing ink, which is a slurry, 
made up of either glass or ceramic powders with the polymeric binder usually Pluronic 
F-127. It is characterized by appropriate rheological properties. Rheological properties 
of the ink are defined by its viscosity, yield stress and dynamic elastic modulus. In ro-
bocasting, Pluronic F-127 has been preferred widely as a binder in BTE applications 
(Baino, et al., 2019; Eqtesadi, et al., 2014). 
Recently, scaffolds based on silicate bioactive glass (47.5B glass) were fabricated using 
robocasting technique for bone regeneration application. Scaffolds had grid-like structure 
and were highly bioactive and amorphous (Baino, et al., 2019). Before that in 2017, 
Mattioli-Belmonte et al. obtained porous multilayer glass-PLGA composite 2D and 3D 
bone like scaffolds using robocasting technique named as pressure-activated microsy-
ringe (PAM) method. Scaffolds were resembling to the topological features of the can-
cellous bone. 3D Scaffolds were successful in aiding proliferation of osteoblast-like cells 
and periosteal-derived scaffolds, showing their applications in bone tissue engineering 
(Mattioli-Belmonte, et al., 2017). 
In the history, Franco et al. were the first who obtained bioceramic scaffolds using ro-
bocasting technique in 2010, their ink was based on ceramic to build HA, β-tricalcium 
phosphate (β-TCP), and biphasic (HA/β-TCP) structures (Franco, et al., 2010). Later, 
robocasting came in trending where commercial glass i.e., 45S5 Bioglass® and 13-93 
glass were processed using this technique by many other researchers. Silicate 13-93 
bioactive glass was produced by Liu et al. in 2013 utilizing robocasting technology to 
evaluate the mechanical properties of the obtained scaffolds. Scaffolds were grid-like 
microstructured, having 300µm pore width and 47% porosity. Compression tests and 
flexural loading were carried out before and after their immersion in SBF in-vitro and in 
rat subcutaneous model in vivo. Scaffolds compressive strength was reduced after 2 
weeks of immersion in SBF and in vivo implantation. Furthermore, brittle mechanical 
response shifted to elastoplastic response was observed longer than 2-4 weeks in vivo. 
These strong porous scaffolds Showed promising result for loadbearing application or 
loaded bone repair (Liu, et al., 2013).  
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In 2014, Eqtesadi et al. obtained 45S5 Bioglass® robocast scaffolds having intercon-
nected porosity under 60 to 80% for a fixed scaffold design. Compressive strength of 
those scaffolds were similar to that of cancellous bone (2-13MPa), even after sintering 
below the crystallization temperature. He admitted that robocasting technique is the only 
technique which can provide with the scaffold, customized external geometry and opti-
mized pore architecture (Eqtesadi, et al., 2014). One more 45S5 Bioglass® scaffold was 
fabricated in 2017 via robocasting technique to investigate the effect of different postpro-
cessing thermal treatments on the scaffold mechanical response by sintering both amor-
phous and crystallized scaffolds. Cell culture tests revealed that crystallization caused 
by sintering scaffolds at 1000⁰C enhanced cells proliferation and long-term viability in 
vitro (Motealleh, et al., 2017). 
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3. MATERIALS AND METHODS  
In this chapter, experimental part of the thesis is explained where first, phosphate bioac-
tive glasses were produced to analyse their properties and select the best glass compo-
sition(s). Then scaffolds fabrication and their characterization are discussed in detail. 
3.1 Glass production and characterization 
3.1.1 Glass preparation 
Phosphate glass batches with the composition; 45P2O5, 2.5B2O3, 2.5SiO2, 10Na2O, 
20CaO, (20-x)SrO, xMgO in Mol% (x = 0, 5 ,10, 15 and 20), presented in Table 3, for 
each batch were prepared by homogeneously mixing high-purity raw chemicals; NaPO3, 
Ca(PO3), NH6PO4, SrCO3, MgO, H3BO3, and SiO2 in a mortar and transferred to the plat-
inum crucible. Chemicals mass were calculated to get 15 grams of glass.  
 
 
Glass  P2O5  B2O3  SiO2  Na2O  CaO  SrO  MgO  
X = 0 45 2.5 2.5 10 20 20 0 
X = 5 45 2.5 2.5 10 20 15 5 
X = 10 45 2.5 2.5 2.5 20 10 10 
X = 15 45 2.5 2.5 2.5 20 5 15 
X = 20 45 2.5 2.5 2.5 20 0 20 
 
Every mixture transferred in a platinum crucible was melted in air in an LHT 02/17 LB 
speed electric furnace (Nabertherm GmbH, Lilienthal, Germany). The melting tempera-
ture was set to 1200°C and the ramp was set to 10°C/min. Final temperature was main-
tained for 30 minutes. 
The melt was then casted in a brass mould and allowed to solidify a little bit after which 
the semi-solid glass was placed in a pre-heated electric muffle furnace (Nabertherm L 
5/11 or L 3/12) for annealing at 400°C for 5 hours to reduce the internal stress. Post-
annealing solid glass was brought to the RT inside the furnace overnight. The glass 
melting thermal profile can be seen in Figure 7. 
Table 3. Compositions of the glasses in (Mol%) 
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Next day, glass was taken out of the annealing furnace and crushed in metallic mortar 
and sieved in ASTM specified test sieves (Gilson Company, Inc., Ohio, USA) to get at 
least 3.5 grams of 125-250µm and <38µm particle size powders. Desired amount was 
obtained and stored in a tube, in a desiccator for the characterization. 
3.1.2 Thermal properties 
In order to determine the thermal properties of the glasses, thermal transitions of the 
glasses were investigated by performing Differential Thermal Analysis (DTA) on 125-
250µm and <38µm sized glass particles using STA 449 F1 Jupiter® (Netzsch-Gerätebau 
GmbH, Selb, Germany) machine. A platinum crucible was filled with 28mg of glass pow-
der and heated at a rate of 10 °C/min from 40-800°C under 50 ml/min flow of Nitrogen. 
The Tg (glass-transition temperature), Tx (onset of crystallization temperature) and Tp 
(crystallization temperature) were revealed by the obtained DTA curves in origin soft-
ware. Tg was considered as the inflection point of the first endothermic event taken from 
the minimum of the first derivative of the DTA curve. Tx was taken as the onset of the 
crystallization peak, using the tangent method. Tp was taken as the maxima of the crys-
tallization peak. The accuracy was about ±3°C. The hot working window ΔT was calcu-
lated using the formula (ΔT = Tx –Tg).  
Figure 7. Pictorial representation of thermal processes for glass formation. 
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3.1.3 In-vitro dissolution test of glasses 
In-vitro dissolution test of both powder sizes (125-250µm and <38µm) was conducted in 
Simulated Body Fluid (SBF) to examine the bioactivity of the glass for 24h, 48h, 72h, 1 
week and 2 weeks. 
Before the test, SBF solution was prepared according to the recipe proposed by Kokubo 
(Kokubo & Takadama, 2006). SBF was obtained after slowly mixing the analytical grade 
chemicals such as NaCl, NaHCO3, KCl, K2HPO4·3(H2O), MgCl2·6(H2O), 1M HCl, 
CaCl2·2(H2O), Na2SO4 and (CH2OH)3CNH2 (Trizma® base) in distilled water. Chemicals 
and their amount used in making SBF are mentioned in the Table 4. After chemicals 
were properly mixed in the distilled water, the volume of SBF was adjusted to 1L and pH 
was set to 7.40 ±0.02 at 37⁰C. Ionic concentration of the SBF can be seen in Table 5. 
SBF solution was stored in a fridge. 
 
 
 
 
 
Chemicals Quantity 
NaCl 7.996 g 
NaHCO3 0.350 g 
KCl 0.224 g 
K2HPO4·3(H2O) 0.228 g 
MgCl2·6(H2O) 0.305 g 
1M HCl 40 ml 
CaCl2·2(H2O) 0.368 g 
Na2SO4 0.071 g 
(CH2OH)3CNH2 6.057 g 
 
 
 
Table 4. Chemicals and their quantities for making SBF 
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Ions 
Concentration in SBF 
(mM) 
Na+ 142.0 
K+ 5.0 
Mg2+ 1.5 
Ca2+ 2.5 
Cl- 148.8 
HCO3- 4.2 
HPO42- 1.0 
SO42- 0.5 
 
 
Dissolution test of the phosphate bioactive glasses was carried out by immersing 75mg 
of powders of each particle size (125-250µm and <38µm) and composition in 50ml of 
SBF in the 120ml of polypropylene (PP) containers (Sarstedt AG & Co, Nümbrecht, Ger-
many) as per the protocol proposed by Maçon et al. (2015). The in-vitro dissolution test 
was done in triplicate. The specimens were left in an orbital Multitron AJ 118 g (Infors, 
Bottmingen, Switzerland) shaker incubator at 37°C at 100 rpm for up to 2 weeks. After 
each time point, samples were taken out of the shaker and their pH were measured using 
S47-K SevenMultiTM pH-meter (Mettler-Toledo LLC, Ohio, USA) at temperature 37.0 ± 
0.2 °C. 1 ml of the solution was extracted from each sample and mixed with 9 ml of Ultra-
pure 1M HNO3. Glass powders were filtered from the solutions using filter paper with the 
pore size less than 8 µm then gently washed with acetone and left to dry overnight at 
room temperature for FTIR-ATR analysis. Ionic concentrations of B, Ca, Mg, P, Si and 
Sr in the SBF solutions were obtained by analyzing the solution using inductively-coupled 
plasma––optical emission spectrometer (Agilent Technologies 5110 inductively coupled 
plasma-optical emission spectrometer (ICP-OES), Santa Clara, CA). Na concentration 
was avoided due to the high initial amount in the SBF solution. For ion concentration 
various wavelengths were used, summed up in Table 6, due to potential interaction be-
tween some of the lines used. Results were expressed by taking average ± standard 
deviation (SD) from the triplicate samples at each time point. 
Table 5. Ions and their concentrations in the Simulated Body Fluid. Modified table from 
(Kokubo & Takadama, 2006) 
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Ions B Ca Mg P Si Sr 
Wavelengths (nm) 249.678 393.366 279.553 213.618 250.690 216.596 
 
3.1.4 Structural properties 
All the glass powders (125-250 µm and <38 µm particle size) before and after immersion 
into SBF underwent Fourier transformation infrared spectroscopy (FTIR) to study the 
structural properties of glasses. The IR spectra of the glass particles were obtained using 
Perkin Elmer Spectrum One FTIR Spectrophotometer in Attenuated Total Reflectance 
(ATR) mode. Every spectrum was the average of 8 scans with the resolution of 1 cm−1 
in the wavenumber range 600-4000 cm-1. All spectra were normalized to the maximum 
intensity band and baseline corrected. 
3.1.5 Sintering of glass powder 
Based on characterization of all glass compositions, two glass compositions were se-
lected to be used in producing scaffolds, i.e. x=10 and x=15. Sintering was conducted 
on <38µm particle size powder of both compositions to reveal optimum sintering temper-
ature before crystallization occurs. Pellets were obtained by filling a metallic mould with 
glass powder and applying 25 MPa of pressure using a hydraulic press. The pellets were 
heat treated in a Nabertherm LT 9/11/SKM electric muffle furnace. Heating was done in 
an air atmosphere with a heating rate of 3°C/min. Temperatures were raised from RT to 
480, 490, 495, and 500 °C and kept at the sintering temperature for 1 hour before being 
allowed to cool down overnight. Resulting samples were subjected to a wide-angle X-
Ray diffraction (XRD; 2θ within 10–70°) analysis using MiniFlex™ (Rikagu, Tokyo, Ja-
pan) after being crushed into fine powders to see if crystallization occurred during the 
heat-treatment. 
 
Table 6. Ions and corresponding wavelengths used in ICP evaluation.  
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3.2 Scaffold fabrication and characterization 
3.2.1 Glass preparation for scaffolds 
In order to get the glass powders for scaffolds, 120g of glass was prepared and crushed 
using a ball mill, Pulverisette type 05. 102 planetary ball mill (Fritsch GmbH, Idar-Ober-
stein). For crushing, the ball mill cycle was set to two cycle of 2 minutes at 800 rpm, with 
a pause of 5 minutes in between cycles. The powder was then sieved to obtain particles 
less than 38µm. 
3.2.2 Physical properties 
Density measurement of the glass is crucial in ink preparation for robocasting scaffolds. 
Therefore, small piece of bulk glass from each composition was taken and density was 
measured using Archimedes’ principle. Firstly, mass of the glass piece was measured in 
air then glass piece was immersed in the liquid (ethanol 96%vol) free of bubbles and the 
mass was measured. The glass density ρglass (g/cm3) was calculated using the equation 
mentioned below. 
 𝜌𝑔𝑙𝑎𝑠𝑠 =  
𝑚𝑎𝑖𝑟
𝑚𝑎𝑖𝑟−𝑚𝑙𝑖𝑞𝑢𝑖𝑑
 × 𝜌𝑙𝑖𝑞𝑢𝑖𝑑        (1) 
Where mair and mliquid are the masses of the glass piece measured in the air and in liquid, 
and ρliquid is the density of ethanol 96%vol used as immersion liquid at RT. Five parallel 
measurements of each glass were obtained and average ± SD are reported. 
3.2.3 Scaffold robocasting 
Prior to the fabrication of scaffolds, ink was prepared through two steps. In first step 
Pluronic solution which works as a binder was made by dissolving Pluronic® F-127 
(Sigma-Aldrich, CAS No. 9003-11-6) in a plastic container filled with distilled water to 
obtain a concentration of 25% by weight. Plastic container was covered with ice in an 
ice-bath and that bath was placed to a magnetic stirrer at room temperature keeping the 
stirring rate at 100-150 rpm. Ice in the bath was refilled when needed to keep the tem-
perature low around the solution and to facilitate the homogeneous dissolution of Plu-
ronic. When the Pluronic solution was clear and transparent, it was stored in the fridge 
below 4°C temperature in a sealed container. Mass of the Pluronic F-127 in the solution 
was determined according to the equation 2 below. 
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑃𝑙𝑢𝑟𝑜𝑛𝑖𝑐 = 𝑃𝑙𝑢𝑟𝑜𝑛𝑖𝑐 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 × 𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑃𝑙𝑢𝑟𝑜𝑛𝑖𝑐 × 𝑀𝑢𝑙𝑡𝑖𝑝𝑙𝑦𝑖𝑛𝑔 𝑓𝑎𝑐𝑡𝑜𝑟  (2) 
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In the second step, ink with 35 vol.% glass concentration was prepared by adding Plu-
ronic solution drop by drop to the glass powder in the plastic pot followed by alternating 
vigorous vibrating mixing around 2500 rpm using Vibrofix VFI electrical shaker (IKA® -
Laboretechnic, Saufen, Germany) for 6-7 times with 1 minute mixing and 30 seconds 
cooling in the ice-bath between each mixing turn. After the mixing was done and homo-
geneous mixture was obtained, visible bubbles were reduced by tapping the ink to get 
bubble free slurry. Ink was transferred in the syringe and exceeding air was removed by 
pushing the piston against the opening of the syringe. Plunger was inserted in the car-
tridge and pressed it to the bottom then adaptor was used to connect both syringe and 
cartridge followed by transferring ink from syringe to the cartridge while acted on plunger 
to avoid transferring air in the cartridge. Tip of the cartridge was sealed with parafilm and 
let it be stabilized for 1 hour in room temperature before printing. Again, here mass of 
the glass in the ink was determined using the equation 3. 
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑔𝑙𝑎𝑠𝑠 = 𝑔𝑙𝑎𝑠𝑠 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 × 𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑔𝑙𝑎𝑠𝑠 × 𝑚𝑢𝑙𝑡𝑖𝑝𝑙𝑦𝑖𝑛𝑔 𝑓𝑎𝑐𝑡𝑜𝑟  (3) 
The multiplying factor is defined as a fixed integer number that has to be adjusted de-
pending on the density of the material used in order to completely fill the cartridge for 
printing. The lower is the density of the material, higher is the multiplying factor. 
After 1 hour of ink stabilization, robocasting was performed using 3Dn-Tabletop (nScrypt 
Inc., Orlando, Florida, USA) which was controlled by the Machine Tool 3.0 system soft-
ware. Plastic tips (Nordson EFD Optimum® SmoothFlow™ tapered dispensing tips) with 
a diameter of 410µm which are designed for the ink extrusion were attached with the 
cartridge front opening and cartridge was fixed to the printing head with the labelled tube 
attached at the back for pressure exertion. Printing height of the scaffold was determined 
by the printing head which was allowed to move only in z-axis whereas, printing table 
under the head was moving in x and y-axis with respect to the printing head to achieve 
the extrusion. Acetate sheets (Colour Copier and Laser Transparency OHP Film, Folex 
AG, Seewen, Switzerland) were placed on the printing table as a substrate for scaffold 
printing due to their flatness, good adhesions with the ink and easiness in detachment of 
the scaffolds from them once they are dry (Baino, et al., 2019).  
Processing parameters were entered in the software to get the scaffolds of desired prop-
erties where the movements of the printing table in x- and y-direction were according to 
the script, written in text file. Speed of displacement was set to 4 mm/s. Pressure for the 
material feed was in the range of 15-18 psi, to maintain constant ink flow from the car-
tridge to the sheet. Scaffold with size of 3.7×3.5 mm (20 layers), every next layer depos-
ited onto the previous layer was rotated to 90⁰ angle to get porous and cylindrical grid 
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like structure. After scaffolds were printed, they were left to dry in RT for 24 hours and 
then removed from the acetate sheet.  
Optimized sintering temperature from previous test was used to sinter the 3D printed 
scaffolds. 
3.2.4 In vitro dissolution test of scaffolds 
The bioactivity of the scaffolds was analysed by using the same protocol mentioned in 
subchapter 3.1.3, but this time there were scaffolds instead of glass powders. Three 
parallel samples of both glass scaffolds compositions along with three blank SBF sam-
ples as a control were incubated for 6h, 24h, 48h, 72h, 1week and 2weeks in 120 ml of 
SBF. The mass of the samples was measured before and post immersion, as dry and 
the mass was quantify using the equation 4. 
𝑀𝑎𝑠𝑠 𝑙𝑜𝑠𝑠 =  
∆𝑊
𝑊₀ 
=
𝑊₀ −𝑊𝑡
𝑊₀ 
∙ 100        (4)  
W₀ represent the initial weight and W t is the post-immersion weight of the scaffolds. 
At each time point the pH of the solutions was measured and 1 ml of SBF was diluted 
into 9 ml of 1M HNO3 for ion concentration measurements. 
3.2.5 Physical and structural properties 
Scaffold parallel samples before and after immersion time were ground to fine powder 
and their structural information were examined by FTIR analysis using the same protocol 
as for powders before robocasting explained in previous subchapter. X-Ray diffraction 
was performed on both compositional sintered scaffolds to confirm that the selected sin-
tering temperature was any good to avoid crystallization after robocasting scaffolds.  
3.2.6 Mechanical Test 
Three parallel scaffold samples before and after immersion time underwent mechanical 
testing using Instron ElectroPuls™ E1000 (All-Electric Dynamic Test Instrument, USA) 
machine interfaced with the Instron Console software to examine the compressive 
strength. Cross-head speed was kept as 5 mm/min and the cell load as 5 kN. Before 
crushing, scaffolds dimensions were measured with the caliper, diameter and height 
were in the range of 4-5 mm. Compressive strengths of the scaffolds were described by 
taking the maximum compression values from each measurement. Results were ex-
pressed as average ± SD.  
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4. RESULTS AND DISSCUSION 
In this chapter, results obtained from the experiments done in the thesis project are pre-
sented and discussed. Phosphate glasses with compositions; 45P2O5, 2.5B2O3, 2.5SiO2, 
10Na2O, 20CaO, (20-x)SrO, xMgO in Mol% (x = 0, 5 ,10, 15 and 20) were prepared. 
They were studied in light of their thermal, structural and in-vitro properties. The most 
promising glasses were 3D printed into scaffolds and their in-vitro dissolution in static 
condition were assessed. 
4.1 Analysis of glass 
4.1.1 Thermal properties 
 
Thermal properties of the glasses with both particle sizes i.e., <38µm and 125-250µm 
are illustrated in DTA thermograms (Figure 8 (a) and (b)). With an increase in MgO con-
tent in the glass compositions, Tg and Tp are increasing linearly, whereas Tx remains 
almost constant within the accuracy of ±3°C in these glass compositions and both parti-
cle sizes. Hot working window (ΔT) of the glass x = 0, 5 and 10 also remained almost 
same. Above 10 mol% of MgO content in the glass shows no crystallization peak which 
can be evidenced in x = 15 and 20. All values are presented in Table 7 and 8.  
Thermal properties of phosphate bioactive glasses rely strongly on their structural fea-
tures such as crosslinking density, phosphate chain, bonding strength (Shih & Chin, 
2001) and composition (Neel, et al., 2009). Thus, shifting of Tg and Tp towards higher 
temperature with increasing of MgO content (Table 7 and 8) is attributed to the replace-
ment of Sr-O bond with Mg-O bond. Increasing of Tg and Tp is due to the higher ion 
potential of the Mg2+ ions and can be explained by the Dietzel’s ionic field strength as 
(𝐼 =  
𝑍
𝑟2
) where Z represents cation charge and r is the radius. Mg2+ has 4.73 Å−2 ionic 
field strength which is higher than other cations present in the glasses especially the 
cation (Sr = 1.56 Å−2) it is replacing (Ma, et al., 2012; Mishra, 2019). This leads to a 
higher tendency of attracting NBO and increase the rigidity of the phosphate network. 
This behaviour is in the agreement with the study done by Islam et al. where magnesium 
was replaced with calcium in phosphate glass and resulted in a decrease in Tg and Tp. 
(Islam, et al., 2017). 
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Figure 8. DTA thermograms of glass (a) <38µm particle size and (b) 125-250µm 
particle size. 
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Glass Tg (°C) ±3°C Tx (°C) ±3°C Tp (°C) ±3°C ΔT = Tx-Tg 
(°C) ±6°C 
x = 0 463 622 663 159 
x = 5 466 626 676 160 
x = 10 469 623 682 154 
x = 15 475 
   
x = 20 483 
   
 
 
 
Glass Tg (°C) ±3°C Tx (°C) ±3°C Tp (°C) ±3°C ΔT = Tx-Tg 
(°C) ±6°C 
x = 0 463 656 685 193 
x = 5 467 660 708 193 
x = 10 469 657 728 188 
x = 15 475 
   
x = 20 482 
   
 
Table 7. Tg, Tx, Tp and ΔT of glasses having <38µm particle size.  
Table 8. Tg, Tx, Tp and ΔT of the glasses having 125-250µm particle size. 
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Form the Figure 8 (a and b) and Table 7 and 8, one can notice that the Tx of all glass 
compositions having particle size 125-250µm is higher than the Tx in particle size <38µm. 
This behavior is in the agreement with the Chatzistavou et al. study in which they studied 
5 different particle sizes of the bioactive glass and studied thermal behavior of all the 
particle sizes. The thermal analysis revealed that the larger particle sizes were able to 
drag the crystallization temperature to the higher temperature which was assumed to be 
due to particle size effects in heat transfer (Chatzistavrou, et al., 2006). However, it 
should be noted that the dependence of Tp on particle size cannot readily give the infor-
mation regarding the nature of crystallization mechanism i.e., whether it is surface crys-
tallization or internal crystallization (Ray, et al., 1996). The change in peak temperature 
as a function of glass particle size indicates the surface crystallization. Surface crystalli-
zation mechanism is dominant on small particle size. Therefore, based on previous stud-
ies it is expected that the crystallization in small particles are from the surface (Massera, 
et al., 2012). In the case of x = 15 and x = 20, where no crystallization peaks appeared 
is because the kinetics of nucleation and growth are so slow that they are not observed 
in DTA within the time of measurement. ΔT provides the gauge of the resistance to the 
crystallization, therefore, glass with ΔT higher than 100°C have enough stability to be 
sintered without any significant crystallization (Massera, et al., 2015). Evidently, In all 
glass compositions, ΔT is larger than 150°C. 
4.1.2 Structural properties 
 
Structural properties of all glass compositions having particle size <38µm were analyzed 
using FTIR spectroscopy. Obtained spectra were normalized to the band with higher 
intensity which is located at ~887 cm-1. In Figure 9, there are all together 5 bands present 
in the spectra at wavenumbers around 1240, 1080, 887, 775 and 718 cm-1, and a shoul-
der at ~980 cm-1. Absorption bands can be assigned to the phosphate glass network. 
The bands at around 718 and 775 cm-1 can be attributed to P-O-P symmetric stretching 
in metaphosphate structure (LEE, et al., 2009). The highest absorption band located at 
~887 cm-1 can be attributed to the P-O-P asymmetric stretching vibration of bridging ox-
ygen in metaphosphate structure (vas P-O-P Q2) (Shih & Shiu, 2007; Moustafa & El-Egili, 
1998). The shoulder located at ~980 cm-1 and band at ~1080 are assigned to the sym-
metric and asymmetric stretching vibration of PO3
2− in Q1 units. The band peaking at 
around 1240 cm-1 corresponds to the asymmetric vibration of PO2
− in Q2 units (Gao, et 
al., 2004; Neel, et al., 2009).  
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In a pure phosphate network, PO3
2− tetrahedral units are connected with each other by 
three bridging oxygens. The network is disrupted when a modifier oxide is added and 
modifier oxide’s cations take the interstitial positions in the network (Carta, et al., 2007). 
It is observable that the increasing of MgO content didn’t change the bands in all com-
positions in terms of shape and intensity, x = 10 is an experimental error. However, the 
position of the bands is shifting progressively from lower wavenumber to higher wave-
number that might indicate a strengthening of the bonds due to the smaller ionic radius 
of Mg2+ i.e., 0.72 Å compared to the cations it replaces i.e., Sr2+ (1.26 Å) (Shannon, 1976). 
All bands attribution is summarized in Table 9.  
 
 
 
 
 
 
Figure 9. FTIR spectra of all glass compositions with <38µm particle size 
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Wavenumber (cm-1) Attribution Reference 
718-775 vs P-O-P in Q2 
(LEE, et al., 2009) 
887 vas P-O-P in Q2 
(Shih & Shiu, 2007; 
Moustafa & El-Egili, 1998) 
980 vs PO3
2− in Q1 
(Gao, et al., 2004; Neel, et 
al., 2009) 
1080 vas PO3
2− in Q1 
(Gao, et al., 2004; Neel, et 
al., 2009) 
1240 vas PO2
− in Q2 
(Gao, et al., 2004; Neel, et 
al., 2009) 
 
 
4.1.3 In-vitro dissolution test 
Dissolution studies were conducted for all glass compositions and for both particle sizes 
by immersing in SBF for 0, 1, 2, 3, 7 and 14 days to evaluate the impact of increasing 
MgO content on the ion release mechanism of the glass.  
Figure 10 (a) and (b) show the changes in pH of the solutions as compared to the pH of 
blanks SBF as a function of immersion time. Solution’s pH was similar for all glass com-
positions. However, while the pH does not exhibit any significant change within the ac-
curacy of the measurement for the larger particle sizes, particles <38µm (Figure 10a) 
exhibit a drop in pH at day 2, and then remained constant within the accuracy of the 
measurement. So, these glasses upon dissolution remained at the physiological pH. 
 
 
 
 
 
Table 9. Summary of FTIR-ATR bands attributions 
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Figure 10. Change in pH as a function of immersion time of the particle sizes (a) 
<38µm (b) 125-250µm 
37 
(a) 
0 2 4 6 8 10 12 14 16
0,0
0,5
1,0
1,5
2,0
B
 (
m
g
/L
)
Immersion time (days)
 x=0
 x=5
 x=10
 x=15
 x=20
 
(b) 
0 2 4 6 8 10 12 14 16
80
90
100
110
120
C
a
 (
m
g
/L
)
Immersion time (days)
 x=0
 x=5
 x=10
 x=15
 x=20
 
38 
(c) 
0 2 4 6 8 10 12 14 16
20
30
40
50
M
g
 (
m
g
/L
)
Immersion time (days)
 x=0
 x=5
 x=10
 x=15
 x=20
 
(d) 
0 2 4 6 8 10 12 14 16
20
40
60
80
100
120
140
P
 (
m
g
/L
)
Immersion time (days)
 x=0
 x=5
 x=10
 x=15
 x=20
 
39 
(e) 
0 2 4 6 8 10 12 14 16
0,0
0,5
1,0
1,5
2,0
2,5
3,0
S
i(
m
g
/L
)
Immersion time (days)
 x=0
 x=5
 x=10
 x=15
 x=20
 
(f) 
0 2 4 6 8 10 12 14 16
0
5
10
15
20
25
30
35
S
r 
(m
g
/L
)
Immersion time (days)
 x=0
 x=5
 x=10
 x=15
 x=20
 
 
Figure 11. Concentration of (a) B, (b) Ca, (c) Mg, (d) P, (e) Si, (f) Sr ions in SBF as a 
function of immersion time of <38µm particle size glasses. 
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Figure 12. Concentration of (a) B, (b) Ca, (c) Mg, (d) P, (e) Si, (f) Sr ions in SBF as a 
function of immersion time of 125-250µm particle size glasses. 
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Figure 11 and 12 present ion release behaviour of the glasses (x = 0, 5, 10, 15, 20) with 
both particle sizes i.e. <38µm and 125-250µm in SBF recovered after immersion and 
assessed by ICP-OES. In Figure 11, it can be observed that the release of some ions 
(B, P, Ca, Mg) is higher with increasing the MgO concentration. In the case of Si, it ap-
pears that its release does not follow the MgO for SrO substitution. Finally, the Sr release 
decrease with substitution, as expected from the decreasing concentration of Sr. It is 
noteworthy that all ions release over 1 day of immersion and then the ion concentration 
remain fairly constant, indicating that the dissolution process of such small particles is 
rapid. 
The glasses with particle size 125-250µm released ions (B, Mg, P and Sr) linearly for up 
to 14 days. The only exceptions are for Ca and Si ions, which only released for 1 and 3 
days, respectively. The saturation of the ions release curve may be credited to the SBF 
solution becoming saturated with ions released from the glasses that eventually lead to 
the precipitation of a surface layer (Mishra, 2019). 
Usually, Interpreting Ca ion release is challenging. Typically, when bioactive glasses are 
immersed, the Ca concentration in the SBF first increases then either decreases or re-
main constant. Such phenomena are seen in the parallel of decrease in the concentration 
of P ion with respect to immersion time. This behaviour can be the indication of Ca-P 
precipitation on the surface of the material (Massera & Hupa, 2014). 
MgO effect on glass bioactivity depends on the MgO content in the glass and also glass 
overall composition due to the predominant intermediate nature of MgO. Similarly, in one 
study, addition of the MgO in the phosphate bioactive glasses didn’t facilitate the for-
mation of apatite layer but led to the amorphous calcium phosphate (ACP) deposition on 
the surface of the glasses which has been stated as a precursor phase towards formation 
of hydroxyapatite (Islam, et al., 2017).  
Glass particle sizes have a role in the dissolution of the glass in SBF. Dissolution rate 
increases with the decrease in particle size and thus dissolution rate can be controlled 
by varying the particle size (Sepulveda, et al., 2002; Sepulveda, et al., 2000). This be-
haviour can be evidenced in Figure 11 and 12, where particle size less than 38µm 
leached ions faster than the particle size 125-250µm. 
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After the In vitro dissolution study, FTIR was conducted on the glass powders with <38µm 
particle size recovered after the immersion in the SBF for the longest time point i.e. 2 
Figure 13. FTIR spectra of the glasses (a) x=0 and (b) x = 20 with particle size 
<38µm after soaking in SBF for 0h and 2 weeks. 
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weeks. For the FTIR analysis, powders with <38µm particle size was selected due to 
their further usability for scaffold fabrication and 2 weeks time point was chosen to see if 
reactive layer is formed. 
Figure 13 (a) and (b) show the difference in structural changes between x = 0 and 20 
glasses at 0 and 2 weeks immersion time in SBF. It can be seen from both spectra that 
no significant changes occurred in both investigated compositions due to the addition of 
MgO in the glass. However, intensities of the bands have increased at around 718, 775 
and 1080 cm-1 whereas, intensity decreased at around 1240 cm-1 as a function of immer-
sion time in both glasses. One can also observe a band formation in place of shoulders 
at ~1000 and ~1027 cm-1 with uplifted intensity in x = 20 (Figure 13 (b)) after 2 weeks of 
immersion time.  
The decrease in intensity of band at 1240 cm-1 after 2 weeks immersion time indicates 
that the amount of Q2 units decreases. Moreover, the increase in band at 1080 cm-1 can 
indicate the increase in Q1 units (Massera, et al., 2013). These changes in the spectra 
can be related to the depolymerization of the glasses due to a hydration of phosphate 
chains (Clement, et al., 1999). The new bands appeared at ~1000 and ~1027 cm-1 after 
2 weeks of immersion can be attributed to the CaP layer formation at the glass particles 
surface. Increase in intensity of the bands at 718 and 775 cm-1 exhibit the decrease in 
bond length and/or orthophosphate group formation when in contact with SBF (Massera, 
et al., 2013). 
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Figure 14. XRD patterns of x = 10 glass powder sintered at (a) 480°C and (b) 500°C 
temperature. 
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After the characterization of glass powders with all the compositions, x= 10 and 15 were 
selected for scaffold fabrication. They have better resistance to crystallization than the 
glasses without the magnesium and dissolve slower than the Sr-free glasses. XRD was 
performed on the selected glass powders (<38µm) sintered in a pellet form at 480°C and 
500°C temperature to determine the suitable temperature for the processing of scaffolds. 
Both Figures 14 and 15 show the diffraction patterns at (a) 480 and (b) 500 °C. 
As seen from the Figure 14 (a) and 15 (a), no crystallization peaks are observed, and 
broad amorphous halo is formed in the range between 20° to 35° when sintered at 480°C 
temperature which revealed the amorphous nature of the glass. However, crystallization 
peaks appeared for the powders sintered at 500°C (Figure 14 (b) and 15 (b)). It is note-
worthy that the x = 10 contains only one crystallization peak whereas, x = 15 shows more 
than one sharp peaks. It appears that, while the crystallization peak could not be seen 
in the DTA thermogram of x = 15, the crystallization tendency increases with increasing 
MgO. 
 
Figure 15. XRD pattern of x = 15 glass powder sintered at (a) 480°C (b) 500°C tem-
perature. 
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4.2 Characterization of Scaffolds 
Phosphate bioactive glass scaffolds with both compositions x = 10 and 15 were charac-
terized to obtain the significant information regarding the material properties such as 
XRD, to confirm amorphous nature of the glass, In-vitro dissolution, to see ion release 
behaviour of the scaffolds in static condition, FTIR, to observe structural changes of the 
scaffolds and compression test to examine the mechanical strength of the scaffolds. 
For the ink preparation, density of both glass compositions in bulk form was measured 
using Archimedes principle. Density of x = 10 and x = 15 were 2.78 and 2.75 ± 0.02 g/cm-
1, respectively. Density of the glass decreased when MgO increased in x = 15 glass, this 
may be because Mg has a lower molar mass which causes the density to decrease 
(POHJOLA, 2017). 
4.2.1 XRD analysis of the Scaffolds 
After the fabrication of the scaffolds through robocasting technique, all scaffolds were 
sintered at 490°C temperature which was thought to be the suitable temperature for scaf-
folds processing. Post-sintering, one scaffold from each glass composition were ground 
to fine powder and underwent XRD analysis.  
Figure 16 (a) and (b) presents the XRD diffraction pattern of the x = 10 and x = 15 scaf-
folds sintered at 490°C. From the figure, it appears that despite sintering at temperature 
expected to be lower than the crystallization temperature, sharp peaks can be seen. It is 
also interesting to see that the crystallization peaks are sharper and more intense than 
previously reported (Figure 14 (b) and 15 (b)). 
Therefore, it is conceivable that Pluronic in the ink leads to increased tendency of crys-
tallization. Crystallization may be either due to the presence of carbons which sometimes 
remain in the scaffold structure even after organic binder burns off or precipitation of 
reactive layer during the ink process.  
One can also see that the position of the sharp crystallization peaks in XRD pattern of 
glass powders and scaffold glass powder are not the same i.e., in glass powders, crys-
tallization peaks are at around 27.5° whereas, in scaffolds powders, these peaks appear 
at around 29.6°. This can be either due to presence of carbon at the glass particles 
surface which modifies the primary crystal field or remnant of impurities from the ink 
decomposition at the glass surface.  
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Figure 16. XRD diffraction patterns of the robocasted scaffolds of (a) x =10 and (b) x 
= 15 glass compositions 
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4.2.2 In-vitro Dissolution of Scaffolds 
 
0 2 4 6 8 10 12 14
-0,10
-0,05
0,00
0,05
0,10

p
H
Immersion time (days)
 x = 10
 x = 15
 
 
The in-vitro dissolution properties of the robocasted scaffolds were examined by immers-
ing them in the SBF from 6 hours to 14 days. After each time point, pH of the SBF was 
measured and the change in pH, ΔpH, as a function of immersion time is presented in 
Figure 17, respectively. It can be seen that no significant change occurred in the pH 
within the accuracy of measurement for the whole immersion period. Hence, solution 
remained at a physiological pH.  
 
 
 
 
 
 
Figure 17. Change in pH of the SBF upon immersion of scaffolds as function of im-
mersion time. 
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Figure 18. Ion release behavior of the scaffolds containing (a) B, (b) Ca, (c) Mg, (d) 
P, (e) Si, (f) Sr elements in the SBF as a function of immersion time. 
54 
The rate of biodegradation of bioactive material is complex but plays an important role in 
its stability after implantation. In vitro dissolution study is considered helpful to under-
stand the soluble nature of prepared glass, especially in SBF solution where its ions 
affect the network by exchanging ions produced from the glass in the SBF (Gurusamy, 
et al., 2012). Generally, ions are released from the surface of the glass during the bioac-
tivity mechanism; therefore, additional information can be obtained during ionic concen-
tration evaluation in the SBF during dissolution test (Bruckner, et al., 2016). 
Figure 18 shows the B, Ca, Mg, P, Si and Sr ions release profile of scaffolds evaluated 
with ICP-OES. It can be observed in the graphs that there is a progressive release of all 
the ions until 14 days besides a small drop in 3 days time point for all the ions except 
Ca. Ca concentration was increasing linearly until 3 days for x =10 and 2 days for x = 15 
followed by sudden precipitation for the rest of the testing time point. Furthermore, ion 
released trend of x = 15 scaffolds remained lower than x = 10 except Mg and in P, for 
which the release is similar. In all the graphs, one can notice that the plateau was not 
reached.  
The decreasing concentration of Ca ion for the longer time point in the SBF indicates the 
consumption of Ca ion which eventually leads to the precipitation of the reactive layer. 
This is also in agreement with the decrease in P, Mg, and Sr assumed to be also incor-
porated in the reactive layer. Moreover, Ca is already present in the SBF; therefore, the 
solution becomes super-saturated in the early immersion time point (Massera, et al., 
2013; Mishra, et al., 2016). According to the earlier studies, CaO content is important in 
terms of solubility behaviour of the glass and there is a correlation between MgO content 
and Ca ion release; therefore, when the MgO content is increased in the glass, the sol-
ubility decreases (Franks, et al., 2002). 
Overall, there was not great difference observed in the ions released from the scaffolds 
with x = 10 where content of MgO and SrO is same and with x = 15, where MgO content 
is more than SrO in the glass. In both compositional scaffolds, ions were releasing pro-
gressively despites a drop in 3 days time point which can corresponds to the time at 
which the layer starts forming. The precipitation of the reactive layer seems to be faster 
and more pronounced for the x = 15 glass, as shown by the greater drop in Ca, Mg, and 
Sr concentration for this glass. 
If these results are compared with the dissolution studies performed on the glass parti-
cles, ions released did not reach the plateau during scaffolds dissolution studies 
whereas, ions release became stable after 3 days of immersion. The difference can be 
due to the lower specific surface in scaffold compared to particles. 
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Figure 19 shows the mass loss of both compositional scaffolds after each time point in 
the SBF. It can be seen that the mass loss of the scaffolds is between 0 to 3 % after 2 
weeks of immersion time in the SBF which is negligible, scaffold with x = 15 gained mass 
after 6 hours time point which is due to the little SBF absorption. The mass loss result is 
in the agreement with the ΔpH results of the scaffolds as the pH was not changed be-
cause mass loss did not occur. This also proves that the overall dissolution of the two 
scaffolds are fairly similar.  
4.2.3 Mechanical Property 
 
During the development of the bioactive glass scaffolds for the structural bone loss re-
pair, mechanical properties should be comprehensively examined because their proper-
ties change with time (Liu, et al., 2013). That is the reason that besides the most studies 
on mechanical properties of the bioactive glass scaffolds, focus has been on evaluating 
the strength and Young’s modulus in compression of the as-fabricated scaffolds or scaf-
folds that were immersed in SBF (Fu, et al., 2011). 
 
 
Figure 19. Mass loss of robocasted scaffolds after immersion in SBF. 
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Figure 20. Compressive stress vs. strain of (a) x =10 and (b) x = 15 glass scaffolds 
as a function of immersion time. 
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Figure 21. Compressive strength of the (a) x =10 (b) x = 15 robocasted glass scaf-
folds as a function of immersion time.  
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Figure 22. Young’s modulus of the (a) x =10 and (b) x = 15 glass scaffolds as a func-
tion of immersion time. 
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Figure 20 presents the mechanical behaviour of the robocasted scaffolds in compression 
as a function of immersion time in SBF. All scaffolds compressive stresses are charac-
teristic of a brittle material. The force rises rapidly with minimal deformation of the scaf-
fold, until reaching fracture. The maximum force before failure can be assigned to the 
maximum compressive strength while the linear fit of the initial rise in force as a function 
of strain corresponds to the elasticity of the materials. 
Compressive strengths of both compositional scaffolds were measured before and after 
certain immersion time point and the average ± SD obtained are shown in Figure 21. It 
can be seen that over the course of the immersion, the compressive strength does not 
significantly change and remain within 8-16MPa in the case of the scaffold x=10 and 
within 5-9 MPa for the scaffold x=15. The compressive strength results indicate that the 
glass x=10 sintered more effectively than the glass x=15.  
Ideally, scaffold should act as a temporary template that mimics the function of healthy 
bone by facilitating new bone growth while supporting surrounding tissues when im-
planted on load-bearing site. Therefore, scaffold needs to show good mechanical prop-
erties after implantation and not degrade before the healing is completed (Baino, et al., 
2019). The obtained values are within values reported for cancellous bone (2-12 MPa 
(Hench, 1991)) or even higher, indicating that up to 2 weeks, the scaffold can support 
the mechanical load in non-load bearing applications. Variation in the compressive 
strength can be reduced by optimizing the scaffold fabrication process (Baino, et al., 
2019). 
Young’s modulus of three parallel samples of both (a) x = 10 and (b) x = 15 glass scaf-
folds were measured as a function of immersion time in the SBF and average ± SD were 
obtained and plotted which are presented in Figure 22. For both glass scaffolds, the 
Young’s Modulus remain almost unchanged as a function of immersion time in SBF. The 
Young’s modulus of x = 10 and x = 15 glass scaffolds before immersion was 465 ± 94 
MPa and 204 ± 56 MPa and after 2 weeks immersion time was 513 ± 107 and 284 ± 48 
MPa, respectively. It is true for the scaffolds that the porosity of the porous material 
mainly determines the Young’s modulus of the material (Jian, et al., 2015).  
The modulus obtained from the scaffolds were in the range between 460 – 515 and 200 
to 290 MPa for x = 10 and x = 15 glass scaffolds which exist in the range of values 
reported for trabecular bone (100 – 5000 MPa (Fu, et al., 2011)), respectively. It is difficult 
to calculate the absolute values of the Young’s modulus from the compression tests due 
to the scaffolds geometry and large deformation. However, linear fit of the data up to the 
elastic limit can be used to calculate modulus.  
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4.2.4 Structural Properties  
 
Structural analysis was carried out of the fabricated scaffolds to obtain the information 
regarding changes on the surface of the glasses after immersion in SBF. Spectra were 
normalized to the band having highest intensity. 
Figure 23 presents the FTIR spectra of (a) x = 10 and (b) x = 15 glass scaffolds fabricated 
using robocasting technique and immersed in SBF for 0h and 2w time points. Scaffolds 
were ground to fine powder and underwent FTIR spectroscopy. 
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FTIR analysis of the scaffolds revealed that no significant change occurred to the struc-
ture of the scaffolds glass surface. Similar to the glass powder FTIR results before ro-
bocasting, It was observed that in x = 15, the intensity of the band was decreased after 
2 weeks immersion time at ~1240 cm-1 which indicates the decreasing of network con-
nectivity and increasing Q1 units (Mishra, et al., 2016) due to the glass is in contact with 
SBF. A new band peaking with small intensity at ~1000 cm-1 which can be attributed to 
the PO- in Q0 units and could be assigned to CaP layer formation (Massera, et al., 2013). 
Whereas, there was no effect of immersion time and MgO content on the structure of the 
band in scaffold with x = 10 glass. Unlike the intensity increased at ~1080 cm-1 in glass 
powder structure, here it is same in both compositions. Shifting of the bands towards 
higher wavenumber is also in the agreement with the results of glass powder FTIR before 
robocasting. The decrease in intensity of band in x = 15 at 1240 cm-1 after 2 weeks of 
immersion directs the decrease in density of PO bonds with the addition of MgO (G., et 
al., 2012). 
By these results, one can say that, sintering and in-vitro dissolution of the robocasted 
scaffolds even after two weeks did not bring any major change in the structure than the 
glass structure before scaffolds fabrication. 
Figure 23. FTIR spectra of (a) x = 10 and (b) x = 15 glass scaffolds obtained after 0 
and 2 weeks immersion time point in SBF.  
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5. CONCLUSION 
In this thesis work, five compositions of phosphate bioactive glass were prepared. In 
each composition, MgO was increased at the expense of SrO with the aim to investigate 
the thermal and bioactive properties of the glasses. Amongst all, two suitable glass com-
positions were selected for scaffolds fabrication using robocasting technique, followed 
by their in-vitro characterization.  
With an increase in MgO content in the glass, Tg and Tp were increased linearly except 
x = 15 and 20 where, Tp disappeared eventually. Surprisingly, Tx was not changed much 
which ultimately leads to constant ΔT. Ion release behaviour in <38µm particle size was 
higher than 125-250µm particle size in all glass compositions. Additionally, in <38µm 
particle size, after 1 day, ions release became constant. This suggests that ion dissolu-
tion is dependent on the particle size. FTIR result revealed a new band with low intensity 
on x = 20 glass structure after two weeks of immersion in SBF, which indicated the CaP 
layer formation. 
After sintering x = 10 and 15 glass powders at different temperatures, 490°C was con-
sidered to be the suitable sintering temperature for robocasted x = 10 and 15 glass scaf-
folds in order to prevent crystallization in the glass. After scaffolds were sintered, unex-
pected sharp crystallization peaks were observed through XRD. These peaks were as-
sumed to be due to the carbon left from the binder in the scaffold structure during sinter-
ing which might favoured crystallization of the glass. pH of the SBF remained unchanged 
over the course of 2 weeks. Continuous ions release was observed in scaffolds with both 
compositions for 2 weeks immersion in SBF, except there was the drop of ion release in 
2 days time point which indicated the CaP layer formation. This result was evidenced 
from the FTIR result where new band was formed due to the formation of CaP layer, 
otherwise FTIR revealed no major change in the structure of the scaffold glass even after 
2 weeks immersion in SBF. Mechanical strengths of x = 10 and 15 glass scaffolds were 
within the range of cancellous bone. Thus, these scaffolds could be useful in non-load 
bearing applications. 
To sum up, SrO replacement by MgO seems an effective way to enhance thermal prop-
erties as well as bioactive properties of the glasses. Robocasted scaffolds showed good 
mechanical strength for application in non-load bearing applications. In future, more com-
prehensive analysis of the MgO effects could be done to gain further understanding. 
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